Clincosm LogoSign in Get a demo

Infection, Human Immunodeficiency Virus

Showing 26 - 50 of 113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infection, Human Immunodeficiency Virus, HIV Trial in Russian Federation (Dolutegravir 50 mg)

Completed
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Dolutegravir 50 mg
  • Ekaterinburg, Russian Federation
  • +10 more
Jan 31, 2019

Infection, Human Immunodeficiency Virus Trial in Buenos Aires (GSK2248761, Lopinavir/ritonavir, HAART)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • Buenos Aires, Argentina
    GSK Investigational Site
May 4, 2018

Infection, Human Immunodeficiency Virus Trial in Worldwide (BMS-663068 400 mg, BMS-663068 800 mg, BMS-663068 600 mg)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • BMS-663068 400 mg
  • +7 more
  • San Francisco, California
  • +55 more
Oct 16, 2018

Infection, Human Immunodeficiency Virus Trial in Worldwide (BMS-955176, EFV, TDF/FTC)

Terminated
Has Results
  • Infection, Human Immunodeficiency Virus
  • Beverly Hills, California
  • +63 more
Aug 20, 2018

A Prospective, Non-interventional Study of Use of Dolutegravir

Completed
  • Infection, Human Immunodeficiency Virus
  • Freiburg, Baden-Wuerttemberg, Germany
  • +37 more
Aug 10, 2018

Infection, Human Immunodeficiency Virus Trial (BMS-955176, Ortho Cyclen)

Completed
  • Infection, Human Immunodeficiency Virus
  • (no location specified)
Apr 13, 2018

Infection, Human Immunodeficiency Virus Trial in San Antonio (BMS-663068, Darunavir, Cobicistat)

Completed
  • Infection, Human Immunodeficiency Virus
  • San Antonio, Texas
    GSK Investigational Site
Jan 22, 2018

Infection, Human Immunodeficiency Virus Trial in Worldwide (GSK1349572, efavirenz)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • Phoenix, Arizona
  • +34 more
Dec 14, 2017

Infection, Human Immunodeficiency Virus Trial in Worldwide (dolutegravir 50 mg OAD, darunavir 800mg OAD, ritonavir 100mg OAD)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • dolutegravir 50 mg OAD
  • +2 more
  • Birmingham, Alabama
  • +65 more
Dec 14, 2017

Infection, Human Immunodeficiency Virus Trial in United States (744 Tablet, 744 LA Injection, Placebo Tablet)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • 744 Tablet
  • +3 more
  • San Francisco, California
  • +9 more
Dec 13, 2017

Infection, Human Immunodeficiency Virus Trial in United States (GSK1265744 30mg, Placebo, GSK1265744 5mg)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • GSK1265744 30mg
  • +2 more
  • Fort Lauderdale, Florida
  • +3 more
Nov 2, 2017

Infection, Human Immunodeficiency Virus Trial in France, Germany, Spain (GSK2248761 100 mg once daily, GSK2248761 200 mg once

Terminated
Has Results
  • Infection, Human Immunodeficiency Virus
  • GSK2248761 100 mg once daily
  • +2 more
  • Levallois Perret, France
  • +11 more
Oct 16, 2017

Infection, Human Immunodeficiency Virus Trial in Worldwide (GSK2248761 100 mg once daily, GSK2248761 200 mg once daily,

Terminated
Has Results
  • Infection, Human Immunodeficiency Virus
  • GSK2248761 100 mg once daily
  • +2 more
  • Birmingham, Alabama
  • +40 more
Oct 12, 2017

Infection, Human Immunodeficiency Virus Trial in Austin (BMS-663068, Rifabutin, Ritonavir)

Completed
  • Infection, Human Immunodeficiency Virus
  • Austin, Texas
    GSK Investigational Site
Sep 21, 2017

Infection, Human Immunodeficiency Virus Trial in San Antonio (BMS-663068, Maraviroc)

Completed
  • Infection, Human Immunodeficiency Virus
  • San Antonio, Texas
    GSK Investigational Site
Sep 20, 2017

Infection, Human Immunodeficiency Virus Trial in Hamilton (BMS-663068)

Completed
  • Infection, Human Immunodeficiency Virus
  • Hamilton, New Jersey
    GSK Investigational Site
Sep 20, 2017

The Prevalence Of HLA-B*5701

Completed
  • Infection, Human Immunodeficiency Virus
  • Cheek swab & blood test
  • Woolwich, London, London, United Kingdom
  • +7 more
Sep 9, 2017

Infection, Human Immunodeficiency Virus Trial in Buffalo (Raltegravir, GSK2248761, GSK2248761 + Raltegravir)

Completed
  • Infection, Human Immunodeficiency Virus
  • Buffalo, New York
    GSK Investigational Site
Sep 8, 2017

Infection, Human Immunodeficiency Virus Trial in Austin (BMS-663068)

Completed
  • Infection, Human Immunodeficiency Virus
  • Austin, Texas
    GSK Investigational Site
Sep 7, 2017

Infection, Human Immunodeficiency Virus Trial in Nottingham (BMS-663068)

Completed
  • Infection, Human Immunodeficiency Virus
  • Nottingham, United Kingdom
    GSK Investigational Site
Sep 7, 2017

Infection, Human Immunodeficiency Virus Trial in Nottingham (BMS-955176)

Completed
  • Infection, Human Immunodeficiency Virus
  • Nottingham, United Kingdom
    GSK Investigational Site
Sep 7, 2017

Infection, Human Immunodeficiency Virus Trial in Los Angeles (Triumeq)

Unknown status
  • Infection, Human Immunodeficiency Virus
  • Los Angeles, California
    Mills Clinical Research
Sep 5, 2017

Infection, Human Immunodeficiency Virus Trial (GI265235)

Completed
  • Infection, Human Immunodeficiency Virus
  • (no location specified)
Aug 17, 2017

Infection, Human Immunodeficiency Virus Trial in Austin (BMS-955176, Placebo (Part 1), BMS-955176, Moxifloxacin, Placebo (Part

Terminated
  • Infection, Human Immunodeficiency Virus
  • BMS-955176, Placebo (Part 1)
  • BMS-955176, Moxifloxacin, Placebo (Part 2)
  • Austin, Texas
    GSK Investigational Site
Aug 7, 2017

Infection, Human Immunodeficiency Virus Trial in Orlando, Overland Park (BMS-663068, Methadone, Buprenorphine and

Completed
  • Infection, Human Immunodeficiency Virus
  • Orlando, Florida
  • +1 more
Aug 8, 2017